Drug General Information
Drug ID
D0N1MY
Former ID
DNC000183
Drug Name
Alpha-eudesmol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535019]
Structure
Download
2D MOL

3D MOL

Formula
C15H26O
Canonical SMILES
CC1=CCCC2(C1CC(CC2)C(C)(C)O)C
InChI
1S/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h6,12-13,16H,5,7-10H2,1-4H3/t12-,13?,15-/m1/s1
InChIKey
FCSRUSQUAVXUKK-ILWWEHDPSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Voltage-dependent P/Q-type calcium channel alpha-1A subunit Target Info Blocker [535019]
KEGG Pathway MAPK signaling pathway
Calcium signaling pathway
Synaptic vesicle cycle
Retrograde endocannabinoid signaling
Glutamatergic synapse
Cholinergic synapse
Serotonergic synapse
GABAergic synapse
Dopaminergic synapse
Long-term depression
Taste transduction
Type II diabetes mellitus
Morphine addiction
Nicotine addiction
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Ionotropic glutamate receptor pathway
Metabotropic glutamate receptor group III pathway
Metabotropic glutamate receptor group II pathway
Thyrotropin-releasing hormone receptor signaling pathway
Endogenous cannabinoid signaling
GABA-B receptor II signaling
PathWhiz Pathway Pancreas Function
Reactome Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels
Regulation of insulin secretion
WikiPathways Calcium Regulation in the Cardiac Cell
Synaptic Vesicle Pathway
Integration of energy metabolism
Type II diabetes mellitus
References
Ref 535019Alpha-eudesmol, a P/Q-type Ca(2+) channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion. Brain Res. 2000 Aug 4;873(1):94-101.
Ref 535019Alpha-eudesmol, a P/Q-type Ca(2+) channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion. Brain Res. 2000 Aug 4;873(1):94-101.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.